| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michal Fisher is Director at CNSP. Michal Fisher's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $9K at current prices.
Net of sales, the CNSP filings show accumulation of 2,000 shares.
Michal Fisher has 1 Form 4 filing on record in May 2026, as Director at CNS Pharmaceuticals (CNSP), 2026.
The 1 reported transaction was 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 2,000 shares of CNSP at an average $5.00 on May 18, 2026, about $10K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 2,000 | $5.00 | $10,000.00 | New | +14.6% | - |